DementiaPeptides.com

Why this name

Neurodegeneration research runs on peptides — the aggregating fragments that define the pathology, the synthetic sequences used as probes and standards, the peptide-based diagnostics under development. Set beside dementia, the word marks out a defined scientific and commercial field in a phrase anyone in it will parse immediately. There is no ambiguity and no cleverness to explain.

The .com belongs to whoever is building a business here: a custom peptide synthesis house serving neuroscience labs, a diagnostics company developing fluid biomarkers, a specialty CRO, or a scientific publisher covering the area. Acronym names and Greek-letter coinages force every conversation to start with an explanation. This one arrives already understood by principal investigators, procurement staff, and the journalists who cover the field.

Well suited to

• Custom peptide synthesis supplier for neuroscience research
• Fluid biomarker diagnostics developer
• Contract research organization in neurodegeneration
• Scientific news and literature review publication
• Reagent and antibody catalogue for dementia research

Ideal owner A peptide supplier, diagnostics developer, or CRO working in neurodegeneration.